These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differential retinoblastoma and p16(INK4A) protein expression in neuroendocrine tumors of the lung. Dosaka-Akita H; Cagle PT; Hiroumi H; Fujita M; Yamashita M; Sharma A; Kawakami Y; Benedict WF Cancer; 2000 Feb; 88(3):550-6. PubMed ID: 10649246 [TBL] [Abstract][Full Text] [Related]
3. The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung. Beasley MB; Lantuejoul S; Abbondanzo S; Chu WS; Hasleton PS; Travis WD; Brambilla E Hum Pathol; 2003 Feb; 34(2):136-42. PubMed ID: 12612881 [TBL] [Abstract][Full Text] [Related]
4. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922 [TBL] [Abstract][Full Text] [Related]
5. Reduced transcription of the RB2/p130 gene in human lung cancer. Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097 [TBL] [Abstract][Full Text] [Related]
6. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group. Reissmann PT; Koga H; Takahashi R; Figlin RA; Holmes EC; Piantadosi S; Cordon-Cardo C; Slamon DJ Oncogene; 1993 Jul; 8(7):1913-9. PubMed ID: 8390038 [TBL] [Abstract][Full Text] [Related]
7. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities. Swarts DR; Ramaekers FC; Speel EJ Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738 [TBL] [Abstract][Full Text] [Related]
9. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer. Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152 [TBL] [Abstract][Full Text] [Related]
10. Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung. Marchetti A; Felicioni L; Pelosi G; Del Grammastro M; Fumagalli C; Sciarrotta M; Malatesta S; Chella A; Barassi F; Mucilli F; Camplese P; D'Antuono T; Sacco R; Buttitta F Hum Mutat; 2008 May; 29(5):609-16. PubMed ID: 18293376 [TBL] [Abstract][Full Text] [Related]
11. Abnormalities in structure and expression of the retinoblastoma gene in small cell lung cancer cell lines and xenografts in nude mice. Rygaard K; Sorenson GD; Pettengill OS; Cate CC; Spang-Thomsen M Cancer Res; 1990 Sep; 50(17):5312-7. PubMed ID: 2167152 [TBL] [Abstract][Full Text] [Related]
12. Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines. Shapiro GI; Park JE; Edwards CD; Mao L; Merlo A; Sidransky D; Ewen ME; Rollins BJ Cancer Res; 1995 Dec; 55(24):6200-9. PubMed ID: 8521414 [TBL] [Abstract][Full Text] [Related]
13. Decreased expression of 14-3-3sigma in neuroendocrine tumors is independent of origin and malignant potential. Yatabe Y; Osada H; Tatematsu Y; Mitsudomi T; Takahashi T Oncogene; 2002 Nov; 21(54):8310-9. PubMed ID: 12447694 [TBL] [Abstract][Full Text] [Related]
14. Inactivation of the retinoblastoma gene in a human lung carcinoma cell line detected by single-strand conformation polymorphism analysis of the polymerase chain reaction product of cDNA. Murakami Y; Katahira M; Makino R; Hayashi K; Hirohashi S; Sekiya T Oncogene; 1991 Jan; 6(1):37-42. PubMed ID: 1992444 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines. Yaginuma Y; Hayashi H; Kawai K; Kurakane T; Saitoh Y; Kitamura S; Sengoku K; Ishikawa M Exp Cell Res; 1997 Jun; 233(2):233-9. PubMed ID: 9194486 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of p16INK4A inactivation in non small-cell lung cancers. Gazzeri S; Gouyer V; Vour'ch C; Brambilla C; Brambilla E Oncogene; 1998 Jan; 16(4):497-504. PubMed ID: 9484839 [TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuro-endocrine lung carcinomas. Gouyer V; Gazzeri S; Brambilla E; Bolon I; Moro D; Perron P; Benabid AL; Brambilla C Int J Cancer; 1994 Sep; 58(6):818-24. PubMed ID: 7927874 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of nucleoside diphosphate/kinase A/nm23-H1 protein in human lung tumors: association with tumor progression in squamous carcinoma. Gazzeri S; Brambilla E; Negoescu A; Thoraval D; Veron M; Moro D; Brambilla C Lab Invest; 1996 Jan; 74(1):158-67. PubMed ID: 8569178 [TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer. Xing EP; Yang GY; Wang LD; Shi ST; Yang CS Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761 [TBL] [Abstract][Full Text] [Related]
20. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]